Separating FKBP51 inhibition from mTOR inhibition in anticancer therapy may sometimes be useful, according to recent studies that propose a role for autophagy in promoting cancer survival and enhancing the threshold for apoptosis [80]. The gene discussed is MTOR; the disease is cancer.